Squarepoint Ops LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $204,817 - $240,352	200 Added 1.3%	15,600 $16.4 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $2.47 Million - $3 Million	-2,800 Reduced 15.38%	15,400 $16.2 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $9.66 Million - $10.6 Million	10,700 Added 142.67%	18,200 $17.5 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $2.48 Million - $2.82 Million	3,200 Added 74.42%	7,500 $6.59 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $490,021 - $581,245	700 Added 19.44%	4,300 $3.09 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $3.47 Million - $4.22 Million	-5,100 Reduced 58.62%	3,600 $2.96 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $282,356 - $306,556	400 Added 4.82%	8,700 $6.28 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $2.18 Million - $2.75 Million	-3,800 Reduced 31.4%	8,300 $5.72 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $54,835 - $73,884	100 Added 0.83%	12,100 $7.15 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $3.27 Million - $3.84 Million	5,500 Added 84.62%	12,000 $8.38 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $652,176 - $805,164	1,200 Added 22.64%	6,500 $4.11 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $172,209 - $204,288	300 Added 6.0%	5,300 $3.21 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $6.05 Million - $7.15 Million	-12,800 Reduced 71.91%	5,000 $2.79 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $5.72 Million - $7.02 Million	12,800 Added 256.0%	17,800 $8.42 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $2.39 Million - $3.04 Million	5,000 New	5,000 $2.42 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account